top of page

Dr Christine Lovely: Genetic Subtype Research in Small Cell Lung Cancer

Christine Lovly, MD, PhD

Associate Professor of Medicine, Division of Hematology-Oncology

Ingram Associate Professor of Cancer Research

Vanderbilt University Medical Center

Vanderbilt Ingram Cancer Center

SCLC Meeting 08.22.2023





About the Speaker

Christine M. Lovly, MD, PhD is currently an Associate Professor of Medicine with tenure at the Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center. She received a B.A. in chemistry from Johns Hopkins University followed by M.D. and Ph.D. degrees as part of the Medical Scientist Training Program at Washington University in St. Louis, MO. She then completed internal medicine residency and medical oncology subspecialty training at Vanderbilt University. During her final year of fellowship, she was the Jim and Carol O'Hare Chief Fellow. She started on faculty at Vanderbilt in July 2013 as a physician scientist, splitting her time between clinical care and laboratory research. Her laboratory research is directed at understanding and developing improved therapeutic strategies for specific clinically relevant molecular subsets of lung cancer.


Dr. Lovly has received grant funding from NIH/NCI, the Conquer Cancer Foundation of the American Society of Clinical Oncology, the American Cancer Society, the Damon Runyon foundation, the LUNGevity foundation, the V Foundation, the American Association for Cancer Research, and Lung Cancer Foundation of America / International Association for the Study of Lung Cancer. She is an active member in the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (IASLC), and the American Association for Cancer Research (AACR). Dr. Lovly is also an elected member of the American Society for Clinical Investigation (ASCI) and a member of the Editorial Board for Cancer Discovery and JCO Precision Oncology. She serves on the Scientific Leadership Boards for the GO2 Foundation for Lung Cancer Research (where she also serves as SLB director), the LUNGevity Foundation, and the Lung Cancer Research Foundation. Dr. Lovly is a member of the AACR Science Policy and Government Affairs committee, co-chair of the Tobacco Products and Cancer subcommittee, and an elected member of the AACR Board of Directors. She serves on the NCCN guidelines panel for Non-Small Cell Lung Cancer and is co-chair of the ECOG-ACRIN Lung Biology Committee. In 2021, Dr. Lovly was awarded the ECOG-ACRIN Young Investigator Award. In 2022, she received the GO2 Foundation Asclepios Award honoring research pioneers in the fight to end lung cancer.




The LiveLung Small Cell Lung Cancer Program is supported in-part by grants from AstraZeneca, Amgen, and Jazz Pharmaceutical.


This Video Content has been made available for informational and educational purposes only. The Video Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on the Site.


LiveLung and speakers hereby disclaim any and all liability to any party for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising directly or indirectly from any use of the Video Content, which is provided as is, and without warranties.

Comments


bottom of page